Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Medicina Clinica|September 7, 2014
[Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients]Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, et al.
Leukemia Research|July 19, 2016
Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasmsAnna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, et al.
Medicina Clinica|May 24, 2014
[Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia]Alicia Senín, Leonor Arenillas, Luz Martínez-Avilés, et al.
Anti-Cancer Drugs|November 25, 2011
Multicenter, phase II, nonrandomized study of docetaxel plus trastuzumab every 21 days as the primary therapy in metastatic breast cancer overexpressing HER2Sonia Servitja, Manuel Ramos, Miguel Gil, et al.
Gynecologic Oncology|August 2, 2005
Large cell lymphoma-like reaction in a cervical polypFrancesc Alameda, Beatriz Bellosillo, Teresa Baró, et al.
The Journal of Dermatology|March 14, 2012
Cutis laxa-like mycosis fungoidesDaniel López Aventín, Fernando Gallardo, Inmaculada Gil, et al.
The American Journal of Pathology|January 27, 2004
Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survivalAntonio Martinez, Beatriz Bellosillo, Francesc Bosch, et al.
British Journal of Haematology|January 12, 2011
Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patientsCarlos Besses, Alberto Alvarez-Larrán, Luz Martínez-Avilés, et al.
Acta Dermato-Venereologica|May 6, 2021
Diagnostic Value of Genotypic Analysis in Primary Cutaneous Lymphomas using Standardized BIOMED-2 Polymerase Chain Reaction Protocols: Experience in Daily Clinical PracticeDaniel López Aventín, Fernando Gallardo, Luis Colomo, et al.
The American Journal of Surgical Pathology|September 15, 2005
CD20-negative T-cell-rich B-cell lymphoma as a progression of a nodular lymphocyte-predominant Hodgkin's lymphoma treated with rituximab: a molecular analysis using laser capture microdissectionLara Pijuan, Luis Vicioso, Beatriz Bellosillo, et al.
Pageof 22